NVCT R&D Expenses
Nuvectis Pharma Inc · R&D Expenses
NVCT R&D Expenses
Latest reported$4.68Mperiod ending
NVCT Quarterly R&D Expenses ($0.00 → $4.68M)
Quarterly R&D Expenses
High-resolution chart · PNG
NVCT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 4,684,000 | |
| 4,106,000 | |
| 5,086,000 | |
| 5,774,000 | |
| 3,613,000 | |
| 3,680,000 | |
| 4,496,000 | |
| 2,819,000 | |
| 2,943,000 | |
| 2,660,000 | |
| 4,265,000 | |
| 4,486,000 | |
| 4,262,000 | |
| 2,367,000 | |
| 4,397,000 | |
| 4,520,000 | |
| 2,505,000 | |
| 1,805,000 | |
| 1,144,000 | |
| 4,156,000 | |
| 4,245,000 | |
| 0 |